Navigation Links
XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca
Date:10/10/2007

NEW YORK, Oct. 10 /PRNewswire/ -- HealthShares(TM) Inc., an investment company with a family of 20 fund portfolios, today announced its Board of Directors has approved the transfer of its 19 currently NYSE-listed HealthShares exchange-traded funds (ETFs) to the NYSE Arca trading platform in accordance with NYSE Euronext requirement to transfer of all ETFs to the NYSE Arca LMM platform. The transfer is expected to be completed prior to October 31, 2007. The transfer is expected to be completed by October 26, 2007.

The ETFs scheduled to migrate to NYSE Arca include:

HealthShares Autoimmune-Inflammation ETF HHA

HealthShares Cancer ETF HHK

HealthShares Cardio Devices ETF HHE

HealthShares Cardiology ETF HRD

HealthShares Composite ETF HHQ

HealthShares Dermatology & Wound Care ETF HRW

HealthShares Diagnostics ETF HHD

HealthShares Emerging Cancer ETF HHJ

HealthShares Enabling Technologies ETF HHV

HealthShares European Drugs ETF HRJ

HealthShares European Medical Products & Devices ETF HHT

HealthShares GI/Gender Health ETF HHU

HealthShares Infectious Disease ETF HHG

HealthShares Metabolic-Endocrine Disorders ETF HHM

HealthShares Neuroscience ETF HHN

HealthShares Ophthalmology ETF HHZ

HealthShares Orthopedic Repair ETF HHP

HealthShares Patient Care Services ETF HHB

HealthShares Respiratory/Pulmonary ETF HHR

About HealthShares(TM)

XShares Advisors LLC, a financial services company based in New York, is the creator of the HealthShares(TM) family of 20 Exchange Traded Funds (ETFs), of which 19 are currently trading. HealthShares(TM) ETFs are organized into therapeutic 'Verticals' and represent specific areas of the healthcare, life science and biotechnology industries. Each Vertical addresses a distinct sub-segment of healthcare, such as the diagnosis and treatment of specific therapeutic areas (e.g. cardiology, cancer, infectious disease, etc.) and the development of medical devices (e.g. orthopedic repair, cardio devices, etc.).

Each ETF tracks an index of 22-25 stocks and offers institutional and individual investors a more precise financial instrument that leverages the potential of healthcare investing while mitigating the risks of single stock picking. For more information, visit the company's website at http://www.healthsharesinc.com.

About XShares

XShares Advisors LLC, a subsidiary of XShares Group LLC, is a registered investment advisor that provides investment advisory services to Exchange Traded Funds. XShares also partners with major institutions and index providers seeking to bring innovative Exchange Traded Funds to market using its administrative platform. In addition, XShares creates and licenses distinctive intellectual property for its ETFs, developing products that allow for innovative trading strategies and alternative investments for the financial community. For more information, visit the website at http://www.xsharesadvisors.com.

An Investor should consider the fund's investment objective, risks, charges and expenses carefully before investing. For this and more complete information about the fund call 800.925.2870 or visit the website http://www.healthsharesinc.com for a prospectus. Please read the prospectus carefully before investing.

There are risks involved with investing in ETFs including possible loss of money. HealthShares(TM) are not actively managed and are subject to risks similar to stocks, including those related to short selling and margin maintenance. Losses from short sales may be unlimited, and losses from purchases on margin may exceed original investment. HealthShares(TM) ETFs are subject to increased risks associated with investing in a specific sector compared to a more diversified investment, as well as unique risks associated with the healthcare and biotechnology sector (i.e., government regulation, patent regulation, etc.). The ETFs face additional risks attributable to their investments in small and medium capitalization companies which are subject to higher volatility than larger, more established companies. In addition, they are invested in a limited number of securities and a decline in the value of these investments would cause the fund's overall value to decline to a greater degree than in a less concentrated portfolio. Global or International Funds invest in foreign securities that will be subject to certain risks not associated with domestic securities, such as currency fluctuations, and changes in political and economic conditions. The prospectus is not an offer to buy or sell the portfolio shares, nor is the fund soliciting an offer to buy its shares in any jurisdiction where the offer or sale is not permitted.

HealthShares(TM) Exchange Traded Funds are distributed by ALPS Distributors, Inc.

XShares Advisors LLC and ALPS Distributors, Inc. are unaffiliated entities.

HSI 319 Exp. 12/31/07

Contact Information

For XShares:

Melissa Kanter

Edelman

212-704-8261

melissa.kanter@edelman.com


'/>"/>
SOURCE HealthShares(TM) Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. No link between blood groups and prostate cancer
2. Consumer group seeks Sibutramine ban
3. Suicide risk high in 12-17 Age Group
4. Religious groups overcome objections to cervical cancer vaccines
5. Wockhardt Group Plans Hospital In Delhi By End-2007
6. Group Suicides On The Rise In Japan
7. Yogic Moments: Age Old Yoga, Benefits All Age Groups
8. Group Jogging More Beneficial To Health Than Solo Jogging
9. Plastic Surgery Is Primetime among Ethnic Groups
10. Study Finds Online Support Groups Emotionally Benefit Women Suffering From
11. Specialist Services Can Help Ethnic Groups To Tackle Alcohol Misuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
Breaking Medicine Technology: